curasan AG, let's fix some bones biotech

Key numbers
Market Cap 20M EUR
Sales 4M EUR
Net Income 800K EUR
EPS 0,11 EUR
P/E 27
Cash 3M EUR
LT Debt 0 EUR
Assets 17M EUR
Liabilities 3M EUR
Shares Outstanding 6,800,000
Float 3,800,000
Major investors
Company founder, executive 33% held in a family trust
Wegold Edelmetalle 10%

Resume: curasan AG has signed an agreement which provides Zimmer Dental Inc, Carlsbad, CA, (USA) with exclusive global distribution rights for Osbone®, Ceracell® and Osseolive® synthetic bone grafting products for regenerative dental applications....(entering US market with strong partner)

curasan Inc. has signed an exclusive supply agreement with TransCorp Spine Inc., Michigan, USA, for Cerasorb® Ortho block forms used to repair vertebral bone channels created during surgeries to decompress neural tissue in the spine.

Bottom line: first time profitable EBIT & EPS from product sales, no debt, assets are much bigger than liabilities, big market for products, very low market cap, high insider ownership...you decide.